Amends the Federal Food, Drug, and Cosmetic Act to prohibit the Secretary of Health and Human Services from approving an application for a drug the intended use of which would infringe the right to life, including a drug intended to assist with suicide or induce an abortion. Deems past approved applications for such drugs to be withdrawn and deems such drugs to be adulterated.
[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3553 Introduced in House (IH)]
109th CONGRESS
1st Session
H. R. 3553
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the
approval of any drug that infringes the right to life, and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
July 28, 2005
Mr. Gingrey introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the
approval of any drug that infringes the right to life, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. FEDERAL FOOD, DRUG, AND COSMETIC ACT; PROHIBITION AGAINST
APPROVAL OF DRUG INFRINGING RIGHT TO LIFE.
Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
355) is amended by adding at the end the following subsection:
``(o)(1) Notwithstanding any other provision of this section, the
Secretary may not approve an application under subsection (b) or (j)
for a drug whose intended use would infringe the right to life. Drugs
whose approval is prohibited under the preceding sentence include a
drug intended to assist with the act of suicide and a drug intended to
induce an abortion.
``(2) Effective upon the expiration of 30 days after the effective
date of this subsection--
``(A) the approved application under subsection (b) or (j)
of any drug whose intended use infringes the right to life
within the meaning of paragraph (1) is deemed to have been
withdrawn under subsection (e) or (j)(6), respectively; and
``(B) a drug to which subparagraph (A) applies shall be
considered adulterated for purposes of section 301.''.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line